Karyopharm Therapeutics (KPTI) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

KPTI is expected to report earnings to rise 42.85% to -28 cents per share on October 31

Karyopharm Therapeutics KPTI Stock Earnings Reports

Q3'24

Est.

$-0.29

Q2'24

Beat

by $0.11

Q1'24

Beat

by $0.01

Q4'23

Missed

by $0.05

Q3'23

Missed

by $0.02

The last earnings report on August 06 showed earnings per share of -20 cents, beating the estimate of -31 cents. With 933.12K shares outstanding, the current market capitalization sits at 90.26M.

View a ticker or compare two or three

Compare

KPTI

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For KPTI
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

85 Wells Avenue

Phone

+1 617 658-0600

Employees

325

Web

https://www.karyopharm.com